Publications by authors named "Isabelle de Monestrol"

Claim this Profile
L
Lived experiences for individuals with cystic fibrosis who have undergone lung transplantation: a qualitative study.
Ulrika Skogeland, Isabelle de Monestrol, Terezia Pincikova, Tove Godskesen

BMC Nurs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study.
Jakob Medbo, Henrik Imberg, Christine Hansen, Christina Krantz, Isabelle de Monestrol

Pediatr Pulmonol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and clinical implementation of an LC-HRMS method for ivacaftor, lumacaftor, tezacaftor and elexacaftor in human plasma and breast milk.
Anna B Hansson, Hjalmar Wadström, Erik Eliasson, Mahasin Al Shakirchi, Isabelle de Monestrol

Anal Bioanal Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.
Julie Semenchuk, Yumi Naito, Susan C Charman, Siobhán B Carr, Stephanie Y Cheng, Isabelle de Monestrol

J Cyst Fibros· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, economic, and societal burden of cystic fibrosis and the impact of the CFTR modulator, lumacaftor/ivacaftor: an assessment using linked registry data in Sweden.
Anders Lindblad, Isabelle de Monestrol, Marita Gilljam, Christina Krantz, Lisa J McGarry

J Med Econ· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden.
Mahasin Al Shakirchi, Kimmo Sorjonen, Lena Hjelte, Lena Klingspor, Peter Bergman, Isabelle de Monestrol

Ther Adv Respir Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators.
Carla Colombo, Grant A Ramm, Anders Lindblad, Fabiola Corti, Luigi Porcaro, Isabelle de Monestrol

J Cyst Fibros· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses.
Aleksandra Kowalik, Isabelle de Monestrol, Kimmo Sorjonen, Knut Brockow, Theo Gülen

Br J Clin Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Siobhán B Carr, Elliot McClenaghan, Alexander Elbert, Albert Faro, Rebecca Cosgriff, Isabelle de Monestrol

J Cyst Fibros· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study.
Carla Colombo, Gianfranco Alicandro, Mark Oliver, Peter J Lewindon, Grant A Ramm, Isabelle de Monestrol

J Cyst Fibros· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Colonization on Lung Function in Patients with Cystic Fibrosis.
Mahasin Al Shakirchi, Kimmo Sorjonen, Lena Klingspor, Peter Bergman, Lena Hjelte, Isabelle de Monestrol

J Fungi (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, Elina Aleksejeva, Egil Bakkeheim, Isabelle de Monestrol

ERJ Open Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccine prioritisation for people with cystic fibrosis.
Siobhán B Carr, Rebecca Cosgriff, Satenik Harutyunyan, Peter G Middleton, Rasa Ruseckaite, Isabelle de Monestrol

J Cyst Fibros· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
Lutz Naehrlich, Annalisa Orenti, Fiona Dunlevy, Irena Kasmi, Satenik Harutyunyan, Isabelle de Monestrol

J Cyst Fibros· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.
Robert Bain, Rebecca Cosgriff, Marco Zampoli, Alexander Elbert, Pierre-Régis Burgel, Isabelle de Monestrol

J Cyst Fibros· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
Elliot McClenaghan, Rebecca Cosgriff, Keith Brownlee, Susannah Ahern, Pierre-Régis Burgel, Isabelle de Monestrol

J Cyst Fibros· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function.
Mahasin Al Shakirchi, Lena Klingspor, Peter Bergman, Lena Hjelte, Isabelle de Monestrol

Int J Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences of Individuals Awaiting Lung Transplantation.
Ulrika Skogeland, Isabelle de Monestrol, Tove E Godskesen

Respir Care· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of allergic bronchopulmonary aspergillosis on FEV in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis.
Athanasios G Kaditis, Michael Miligkos, Anna Bossi, Carla Colombo, Elpis Hatziagorou, Isabelle de Monestrol

Arch Dis Child· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does newborn screening influence the young cystic fibrosis cohort included in national registries?
Kris De Boeck, Anne Munck, Isabelle de Monestrol, Vincent Gulmans, Lydie Lemonnier

Eur Respir J· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening.
Isabelle de Monestrol, Asa Klint, Pär Sparén, Lena Hjelte

Paediatr Perinat Epidemiol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental support for newborn screening for cystic fibrosis.
Isabelle de Monestrol, Agneta Bergsten Brucefors, Birgitta Sjöberg, Lena Hjelte

Acta Paediatr· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease.
Abul Kalam Azad, Robert Rauh, François Vermeulen, Martine Jaspers, Judit Korbmacher, Isabelle de Monestrol

Hum Mutat· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European best practice guidelines for cystic fibrosis neonatal screening.
Carlo Castellani, Kevin W Southern, Keith Brownlee, Jeannette Dankert Roelse, Alistair Duff, Isabelle de Monestrol

J Cyst Fibros· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis